Compare NX & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NX | CYRX |
|---|---|---|
| Founded | 1927 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 819.4M | 814.9M |
| IPO Year | 2008 | 2008 |
| Metric | NX | CYRX |
|---|---|---|
| Price | $19.77 | $17.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $28.00 | $13.31 |
| AVG Volume (30 Days) | ★ 473.4K | 457.0K |
| Earning Date | 06-04-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.64% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ 0.57 | N/A |
| Revenue | ★ $1,837,641,000.00 | $176,177,000.00 |
| Revenue This Year | $4.26 | $11.06 |
| Revenue Next Year | $1.77 | $8.45 |
| P/E Ratio | $33.82 | ★ N/A |
| Revenue Growth | ★ 43.81 | N/A |
| 52 Week Low | $11.04 | $7.61 |
| 52 Week High | $23.33 | $17.98 |
| Indicator | NX | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 47.36 | 64.59 |
| Support Level | $17.39 | $14.55 |
| Resistance Level | $21.00 | N/A |
| Average True Range (ATR) | 0.89 | 0.57 |
| MACD | -0.19 | 0.14 |
| Stochastic Oscillator | 18.01 | 82.30 |
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.